Vaginal Microbiota as a Decisive Factor in Vaginal Prosthetic Surgery
1 other identifier
observational
41
0 countries
N/A
Brief Summary
Retrospective analysis of vaginal microbiota in the post-operative course of patient operated for genital prolapse with vaginal mesh with or without mesh related complication
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Primary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 26, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedSeptember 12, 2016
August 1, 2016
August 26, 2016
September 9, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Microbiota diversity (Shannon's H index)
Day 0
Eligibility Criteria
Females aged 18 and over who have consented for vaginal mesh surgery for pelvic organ prolapse at the Nîmes University Hospital, France
You may qualify if:
- Females aged 18 and over who have consented for vaginal mesh surgery for pelvic organ prolapse at the the Nîmes University Hospital, France
You may not qualify if:
- Pregnant or breast feeding
- Unwilling or unable to complete questionnaire or give valid consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2016
First Posted
September 7, 2016
Primary Completion
June 1, 2016
Last Updated
September 12, 2016
Record last verified: 2016-08